551 related articles for article (PubMed ID: 27571188)
1. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
2. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
3. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
4. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
[TBL] [Abstract][Full Text] [Related]
5. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H; Cao H; Cao J; Zhang L
Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
[TBL] [Abstract][Full Text] [Related]
6. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
7. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
[TBL] [Abstract][Full Text] [Related]
8. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
[TBL] [Abstract][Full Text] [Related]
9. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
[No Abstract] [Full Text] [Related]
10. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
[TBL] [Abstract][Full Text] [Related]
12. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
13. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
14. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.
Ribeiro VB; Kogure GS; Lopes IP; Silva RC; Pedroso DCC; Ferriani RA; Furtado CLM; Reis RMD
Arch Endocrinol Metab; 2019 Jul; 63(4):417-426. PubMed ID: 31365630
[TBL] [Abstract][Full Text] [Related]
15. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.
Amato MC; Magistro A; Gambino G; Vesco R; Giordano C
Eur J Endocrinol; 2015 Jan; 172(1):79-88. PubMed ID: 25342852
[TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.
Androulakis II; Kandaraki E; Christakou C; Karachalios A; Marinakis E; Paterakis T; Diamanti-Kandarakis E
Clin Endocrinol (Oxf); 2014 Sep; 81(3):426-31. PubMed ID: 24601936
[TBL] [Abstract][Full Text] [Related]
18. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.
Huang R; Cheng Z; Jin X; Yu X; Yu J; Guo Y; Zong L; Sheng J; Liu X; Wang S
Ann Med; 2022 Dec; 54(1):622-632. PubMed ID: 35175162
[TBL] [Abstract][Full Text] [Related]
20. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.
Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
